Laboratory capabilities
CellCarta provides integrated capabilities in immunology, histopathology, proteomics, and genomics, alongside sample management and logistics solutions.
Source: LinkedIn company description · Retrieved November 17, 2026

CellCarta is a global CRO laboratory serving the biopharmaceutical and biotechnology industries.
CellCarta operates fully owned, harmonized laboratories across North America, Europe, Australia, and China, with capabilities in immunology, histopathology, proteomics, and genomics. CellCarta supports biomarker programs from early translational research through late-stage clinical development and companion diagnostic advancement.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
CellCarta provides integrated capabilities in immunology, histopathology, proteomics, and genomics, alongside sample management and logistics solutions.
Source: LinkedIn company description · Retrieved November 17, 2026
CellCarta’s scientific teams guide assay design, development, validation, and troubleshooting.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 7, 2026, September 19, 2026, October 8, 2026, November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.